We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Web-Based CAD System for Synthetic Biology Designs DNA Sequences in Minutes

By LabMedica International staff writers
Posted on 24 Sep 2009
A web-based computer-assisted design (CAD) environment for synthetic biology is under development, and after completion of the design process, the sequence can be downloaded for synthesis or further analysis. More...
Users who elect to create a personal account on the system can customize their workspace by creating their own parts libraries, adding new parts to the libraries, or reusing designs to quickly generate sets of related constructs.

The U.S. National Science Foundation (NSF; Arlington, VA, USA) has awarded a three-year US$1.4 million grant to Dr. Jean Peccoud, associate professor at the Virginia Bioinformatics Institute (VBI) at Virginia Polytechnic Institute and State University (Virginia Tech; Blacksburg, VA, USA), to develop the GenoCAD application.

Synthetic biology, a rapidly emerging area of biologic research, applies methods developed in engineering to design artificial biologic systems that meet user-defined specifications. It has also been used to redesign natural systems to better understand the fundamental characteristics of living organisms. "We are considering DNA as a language to program living organisms instead of computers," said Dr. Peccoud. "This analogy has led us to apply methods and results from computer science to biology. In particular, rules describing how different functional elements should be combined can be described in the language grammar."

The GenoCAD point-and-click user interface guides the user through the process of designing new sequences. By successively clicking on icons representing structural features or functional blocks, complex DNA sequences composed of dozens of functional blocks can be designed in a matter of minutes. "The development of GenoCAD will be a community-driven project," said Dr. Peccoud. "We intend to involve the synthetic biology research community in helping to advance this project in such a way that it meets the needs of a wide user base." The use of the public version of GenoCAD is free to anyone, while the open source distribution of the software makes it possible for research groups to install GenoCAD on their own servers and, if required, customize it to meet specific needs.

Early applications for GenoCAD include the development of vaccines, sensing devices for biodefense, and metabolic pathways for biofuel production.

The Virginia Bioinformatics Institute at Virginia Tech has a research platform based on understanding the "disease triangle" of host-pathogen-environment interactions in plants, humans, and other animals.

Related Links:

Virginia Bioinformatics Institute at Virginia Tech




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.